ReleaseWire Connect

Hematology instruments are indispensable diagnostic tools and continue to sustain a strong position in the Global Healthcare industry. They include analyzers, flow cytometers, coagulation analyzers, and slide strainers. Hematology analyzers are computerized and highly specialized machines that determine the presence, count, and types of cellular elements in a blood sample for disease detection and monitoring. They are also used to determine non-cellular parameters of the blood such as hemoglobin and hematocrit. Samples of blood can be processed alone, in batches, or continuously in a hematology analyzer. Hematology reagents are used in conjunction with the analyzers.

A barcode is a systematic representation of data depicted in parallel lines with varied spacing and width. Barcode scanner is an electronic device used to read the information contained in barcode. It works by converting the light energy into electrical energy.

Carbon nanotubes are cylinder-shaped graphite sheets. They may consist of a single layer (SWCNTs) or many layers (MWCNTs). They have high thermal and electrical conductivity and are utilized in a wide variety of applications. Some high growth applications of carbon nanotubes are in electronic devices, electrochemical sensors and biosensors, transistors, lithium-ion (li-ion) batteries, hydrogen storage cells, cathode ray tubes, electrostatic discharge protection and electrical shielding applications.

Gene Therapy Gastrointestinal Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Gastrointestinal Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Gene Therapy Genito Urinary System and Sex Hormones Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Genito Urinary System and Sex Hormones Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Hematological Disorders Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Gene Therapy Immunology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape report provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Immunology Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Gene Therapy Infectious Disease Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Infectious Disease Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Report provides the gene therapy targets which are close to 190 with the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Metabolic Disorders Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.